Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Science, Chinese Academy of Sciences, Shanghai 200031, China.
Inflamm Res. 2010 Oct;59(10):791-808. doi: 10.1007/s00011-010-0208-2. Epub 2010 Jul 1.
Due to the rapid increase of new information on the multiple roles of Toll-like receptors (TLRs), this paper reviews several main properties of TLRs and their ligands and signaling pathways. The investigation of pathogen infections in knockout mice suggests that specific TLRs play a key role in the activation of immune responses. Although the investigation of TLR biology is just beginning, a number of important findings are emerging. This review focuses on the following seven aspects of this emerging field: (a) a history of TLR and ligand studies; (b) the molecular basis of recognition by TLRs: TLR structures, pathogen-associated molecular pattern binding sites, TLR locations and functional responses; (c) cell types in TLR expression; (d) an overview of TLRs and their ligands: expression and ligands of cell-surface TLRs and of intracellular TLRs; (e) TLR-signaling pathways; (f) discussion: TLRs control of innate and adaptive systems; the trafficking of intracellular TLRs to endolysosomes; investigation of TLRs in regulating microRNA; investigation of crystal structure of TLRs with ligand binding; incidence of infectious diseases associated with single nucleotide polymorphisms (SNPs) in TLR genes; risk of cancer related to SNPs in TLR genes; TLR-ligand mediated anti-cancer effects; and TLR-ligand induced chronic inflammation and tumorigenesis; and (g) conclusions.
由于 Toll 样受体 (TLR) 的多种作用的新信息迅速增加,本文综述了 TLR 及其配体和信号通路的几个主要特性。在敲除小鼠的病原体感染研究表明,特定的 TLR 在免疫反应的激活中起关键作用。虽然 TLR 生物学的研究才刚刚开始,但许多重要的发现正在出现。这篇综述主要关注这一新兴领域的以下七个方面:(a) TLR 和配体研究的历史;(b) TLR 识别的分子基础:TLR 结构、病原体相关分子模式结合位点、TLR 位置和功能反应;(c) TLR 表达的细胞类型;(d) TLR 及其配体概述:细胞表面 TLR 和细胞内 TLR 的表达和配体;(e) TLR 信号通路;(f) 讨论:TLR 对先天和适应性系统的控制;细胞内 TLR 向内体溶酶体的运输;TLR 调节 microRNA 的研究;TLR 与配体结合的晶体结构研究;与 TLR 基因中单核苷酸多态性 (SNP) 相关的传染病发病率;与 TLR 基因中的 SNP 相关的癌症风险;TLR-配体介导的抗癌作用;以及 TLR-配体诱导的慢性炎症和肿瘤发生;和 (g) 结论。